Article
miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia
26 Apr 2016
Abstract excerpt
MicroRNAs are subject to precise regulation and have key roles in tumorigenesis. In contrast to the oncogenic role of miR-22 reported in myelodysplastic syndrome (MDS) and breast cancer, here we show that miR-22 is an essential anti-tumour gatekeeper in de novo acute myeloid leukaemia (AML) where it is significantly downregulated. Forced expression of miR-22 significantly suppresses leukaemic cell viability and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
